Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-21

FDA Approved: LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' generic lamivudine as an original generic application for HIV-1 infection and chronic hepatitis B. This marks the availabil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

ORIG AP for LAMIVUDINE (LAMIVUDINE)